Kết quả tìm kiếm - Harper Forbes
- Đang hiển thị 1 - 3 kết quả của 3
-
1
307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3... Bằng Karl D. Lewis, Paolo A. Ascierto, Caroline Robert, Rodrigo Ramella Munhoz, Gabriella Liszkay, Luis De La Cruz Marino, Judit Oláh, Paola Queirolo, Jacek Mackiewicz, Kalpit Shah, Harper Forbes, Christian Hertig, Yibing Yan, Ralf Gutzmer, Grant A. McArthur
Được phát hành 2020Artigo -
2
1102P Clinical benefit in BRAFV600 mutation-positive melanoma defined by programmed death ligand 1 (PD-L1) and/or lactate dehydrogenase (LDH) status: Exploratory analyses from the... Bằng Paolo A. Ascierto, Caroline Robert, Karl D. Lewis, Ralf Gutzmer, Daniil Stroyakovskiy, Helen Gogas, Светлана Проценко, Rodrigo Perez Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov, Georgy M. Manikhas, V. McNally, Harper Forbes, Kalpit Shah, Yuanliang Yan, Grant A. McArthur
Được phát hành 2020Artigo -
3
Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation–positive melanoma Bằng Caroline Robert, Karl D. Lewis, Ralf Gutzmer, Daniil Stroyakovskiy, Helen Gogas, Светлана Проценко, Rodrigo Perez Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov, Ivor Caro, Harper Forbes, Kaustav P. Shah, Y. Yan, H. Li, Grant A. McArthur, Paolo A. Ascierto
Được phát hành 2022Artigo